In the wake of several European countries suspending the use of the AstraZeneca Covid-19 vaccine, the company has said that there has been no evidence of increased blood clot risk from its jab.

The suspensions have come amid several reports of blood clots following vaccinations with the Covid jab developed by the British-Swedish pharmaceutical giant and the University of Oxford.